Help Finding Clinical Trials

Posted by bethf @bethf, May 3, 2023

Having applied for a couple of trials and searching for new ones, I now realize I need help navigating these clinical trial options and doing this takes a great amount of time and expertise. I am doing as much as I can on my end, but it is overwhelming and I need more help. I am now having a recurrence and am considered Stage 4 so I am keenly aware that time is of the essence and the windows of opportunity for me to get into any trials are closing rapidly.

I think what I really need is to personally hire a part-time or full-time person to navigate through clinical trials. Do you know someone or have any recommendations on how to find someone (located anywhere), who has the expertise and can take the lead in determining appropriate trials and making direct contact with study coordinators and principal investigators to expedite the determination of my eligibility, the availability of slots, and guide through the process? Would this role be called "clinical coordinator" or something else?

If you have any suggestions about how to find someone I can personally hire to help me, I would be most grateful. StageIVSurvivor, perhaps you know someone or how to find someone?

Beth

Interested in more discussions like this? Go to the Pancreatic Cancer Support Group.

@askretka

PanCan will be announcing details of a new Phase 3 trial with Oncolytics for their drug Pelareorep Biotech and a Checkpoint Inhibitor
On around 20th of September.
Oncolytics Biotech was granted FastTrack approval in December of 2022. The Checkpoint Inhibitor hasn't been decided yet.

Jump to this post

This announcement brings up memories of two other drugs that were in the PanCan.org Precision Promise Trial Platform as phase III candidates a few years ago. The first one was CPI-613 (Devimistat) by Raphael Pharmaceutical. It was looking very promising in the phase II portion of its trial. It received fast-track status and the Biopharmaceutical company began making plans to bring it to market by hiring executives, support staff for ramping up production and distribution. But when the data was evaluated, it showed no better performance than existing standard of care to which it was compared. What was different between the phase II and phase III portions of the trials? In a phase II trial, the inclusion/exclusion criteria is skewed to accepting healthier patients. Phase III trials are more “real world” accepting patients that are more I’ll with the disease. When the data of the phase III cohort was compared to the control group receiving standard of care, there was no significant difference and in some patients, a slightly worse outcome resulted.

In another Precision Promise trial testing the small molecule drug SM-88 (Racemytyrosine) from Tyme Pharmaceutical, it too looked very promising. The same scenario of no statistical difference was demonstrated in the phase III trial after phase II results looked so promising.

REPLY
@askretka

In simple words, we gave a combination of drugs ( pelareorep+ atezolizumab and chemo) to mPDAC patients, which is one of the worst cancers, and 3/3 “safety run-in” patients showed about 50% reduction in their tumor sizes in just 4 months!This is great 🙂

Early days by Oncolytics Biotech and Roche.

Jump to this post

This is all overwhelming. My brother in law was just diagnosed after going to E.R. for something completely unrelated. So far it has looked like this:
1. Go to E.R. for something unrelated and they do a CT Scan which shows something unusual.
2. They go in to do a biopsy but when they get in there, they don't see it so they just pull back out and schedule an MRI to double check.
3. MRI indicates there is something there. They reschedule the biopsy and go back in to take the biopsy.
4. They think there is something going on with the biopsy but it wasn't clear so they send the results to the UW Wisconsin team to look.
5. The night of the biopsy, he develops painful pancreatitis and ends up in the hospital.
6. A day later they tell him while he's still in the hospital that he has pancreatic cancer. When asked about the stage, they say it's 2B.... but telling us it's very early on.

.It feels like he's been put into a cattle prodding line now. A port is going in on Thursday and he'll start Chemo. I don't feel like they have been thorough enough. So much uncertainty and now he's getting a port put in? Looking to get a second opinion. Spoke with insurance company today. The spot in him is about an inch and a half by an inch big. It's not near the blood vessels. Why don't they just take that out? Why waste the next 5 months shrinking it? I know this may sound ignorant but I'm trying to understand. Does everyone who receives this diagnosis go directly into chemo?
Please help.

REPLY
@askretka

In simple words, we gave a combination of drugs ( pelareorep+ atezolizumab and chemo) to mPDAC patients, which is one of the worst cancers, and 3/3 “safety run-in” patients showed about 50% reduction in their tumor sizes in just 4 months!This is great 🙂

Early days by Oncolytics Biotech and Roche.

Jump to this post

I'm no expert on the possibility of surgery, as I don't qualify. However, if the CT and the MRI show a tumor and the biopsy confirms cancer, then yes, chemo is likely the next step. People on this board have said that typically, MDs want to shrink the main tumor as much as possible before attempting to remove it. Did they mention the possible procedure? All I've read about is the Whipple. Many people on this board have posted about that procedure, so you can likely do a search and find posts with more info.

REPLY
@lrymer

This is all overwhelming. My brother in law was just diagnosed after going to E.R. for something completely unrelated. So far it has looked like this:
1. Go to E.R. for something unrelated and they do a CT Scan which shows something unusual.
2. They go in to do a biopsy but when they get in there, they don't see it so they just pull back out and schedule an MRI to double check.
3. MRI indicates there is something there. They reschedule the biopsy and go back in to take the biopsy.
4. They think there is something going on with the biopsy but it wasn't clear so they send the results to the UW Wisconsin team to look.
5. The night of the biopsy, he develops painful pancreatitis and ends up in the hospital.
6. A day later they tell him while he's still in the hospital that he has pancreatic cancer. When asked about the stage, they say it's 2B.... but telling us it's very early on.

.It feels like he's been put into a cattle prodding line now. A port is going in on Thursday and he'll start Chemo. I don't feel like they have been thorough enough. So much uncertainty and now he's getting a port put in? Looking to get a second opinion. Spoke with insurance company today. The spot in him is about an inch and a half by an inch big. It's not near the blood vessels. Why don't they just take that out? Why waste the next 5 months shrinking it? I know this may sound ignorant but I'm trying to understand. Does everyone who receives this diagnosis go directly into chemo?
Please help.

Jump to this post

@lrymer , I'm sorry to hear about this, but I can share what I know. I was in a similar situation and also felt like a cow getting prodded somewhere with no idea where I was going.

No time to retype my story tonight, but I sent you a Direct Message with my contact info if you want to talk asap this week. Will share what I know.

REPLY

Current research shows surgery is likely more curative with chemo upfront. The logic seems to be that it is systemic so simply removing an active tumor may not end the disease .
Although, many very long term survivors I have met were “one and done” with a successful whipple. Every case is different.

REPLY
@lrymer

This is all overwhelming. My brother in law was just diagnosed after going to E.R. for something completely unrelated. So far it has looked like this:
1. Go to E.R. for something unrelated and they do a CT Scan which shows something unusual.
2. They go in to do a biopsy but when they get in there, they don't see it so they just pull back out and schedule an MRI to double check.
3. MRI indicates there is something there. They reschedule the biopsy and go back in to take the biopsy.
4. They think there is something going on with the biopsy but it wasn't clear so they send the results to the UW Wisconsin team to look.
5. The night of the biopsy, he develops painful pancreatitis and ends up in the hospital.
6. A day later they tell him while he's still in the hospital that he has pancreatic cancer. When asked about the stage, they say it's 2B.... but telling us it's very early on.

.It feels like he's been put into a cattle prodding line now. A port is going in on Thursday and he'll start Chemo. I don't feel like they have been thorough enough. So much uncertainty and now he's getting a port put in? Looking to get a second opinion. Spoke with insurance company today. The spot in him is about an inch and a half by an inch big. It's not near the blood vessels. Why don't they just take that out? Why waste the next 5 months shrinking it? I know this may sound ignorant but I'm trying to understand. Does everyone who receives this diagnosis go directly into chemo?
Please help.

Jump to this post

Went through this with my husband in January. Went to ER for stomach pain and CT showed spot on head of pancreas. He was diagnosed as Stage 1B. They immediately did the Whipple procedure and is currently undergoing 12 treatments of chemotherapy. It is a long, rough road ahead. Please reach out if you have any questions. Praying for you ALL.

REPLY

Two sides of an interesting debate, between two prominent physicians at a cancer conference:

Dr. Jordan Berlin (Vanderbilt), in favor of neoadjuvant chemo followed by surgery:


Dr. Matthew Katz (MD Anderson), in favor of surgery first (when appropriate):

As @gamaryanne states, the logic is that the cancer has already micro-metastasized elsewhere by the time it is diagnosed in the pancreas. Surgery first on the pancreas only would not treat malignant cells that have gone elsewhere, and recovery from the surgery would delay addressing them.

The counterpoint is that maybe it hasn't metastasized anywhere yet, but could progress and metastasize if the chemo is not effective. That point is also addressed in a different conference/debate here:


Having gone the neoadjuvant route myself (6 months of Folfirinox followed by Whipple) and then had a recurrence 3.5 months later, I wish I had done the surgery first, and had total removal of the pancreas rather than just partial (Whipple).

My thoughts are basically:

1) If they had cut out the entire pancreas, cancer could not have come back in my remaining pancreas.

2) If I'm already on insulin and will be on enzymes after Whipple, that part will be no different with total removal, except maybe in quantities.

3) I would rather treat the disease I KNOW is there (pancreas) with a procedure (surgery) I KNOW will remove it than treat disease that MIGHT be there (mets elsewhere) with a regimen (chemo) that MIGHT kill it.

Even though any of the pancreas surgeries have a difficult recovery that delays the start of adjuvant chemo, I would (now) inquire about a combined procedure like HIPEC on the first pass (full internal abdominal wash with chemo during the initial surgery) as a possible way of targeting the micro-mets. It will probably be at least 5-6 weeks after surgery before chemo can start or resume.

But with all that said, I am just a statistically irrelevant sample of one, who did not have any chemo or radiation after my Whipple. The studies cited in the videos still generally favor the neoadjuvant chemo before surgery for larger populations, but you never know who's going to be the exception.

The chemo port will probably come in handy; not a big deal to have it inserted asap.

You will want to find a good surgeon at a center of excellence, and consult him/her asap, because wait times can be long to actually see one. That's one reason to start chemo right away -- it's available.

Even if your BIL starts chemo first, the right surgeon can stop chemo whevever appropriate to do surgery. 3-6 months is a common interval, but less is possible. They generally want 30 days for chemo to clear out of your system before doing surgery, so that would be the only delay to consider if you had a good surgeon willing to go right away.

Sorry to ramble; I'll try to clear it up a little more later. Best wishes for now!

REPLY
@stageivsurvivor

Finding a clinical trial can be a daunting task requiring perseverance. Precision Medicine (molecular profiling by Next Generation Sequencing [NGS] and liquid biopsies) to reveal possible gene mutations driving the cancer helps in narrowing the focus for using Targeted Therapy directed at the mutation. Even with that info, searches can be daunting reading through the scope of the trial and the inclusion/exclusion criteria.

Besides clinicaltrials.org, PanCan.org has a search page and case managers you can call (877.272.6226, M-F, 7:00am-5:00pm PT) that work with staff at CancerCommons.org to do the time consuming work in narrowing down the list of potential trials. LetsWinPC.org partners with EmergingMed.com that also has a staff you can speak with to get more clarification of a specific trial. myTomorrows.com is another clinical trial finder service and the staff takes it a step further- they will help with the enrollment process making the phone calls to principal investigator/ clinical trial nurse coordinator so everything is done and a potential participant just needs have an eligibility exam and to read through and give informed consent. All the services through the above search firms are free of charge.

From personal experience, I had molecular profiling done early on. That allowed me to focus my search. Still it took 14 months to find the perfect fit between between aspects of my case and the trial. I searched clinicaltrials.gov and PanCan.org weekly. As a former cancer researcher, I also was perusing the American Society of Clinical Oncology website one weekend as their annual meeting was underway. I saw an abstract just posted of a “proof of concept” trial detailing the results of the two participants. The abstract hinted a clinical trial was to result from the data.

I called clinicaltrials.gov and they knew and had nothing about it. Same for PanCan.org. So using the internet, I found contact info on the first author of the paper and called PanCan.org if they would call and make the introduction about my case. They did and that led to being the first enrolled in the trial and going on to have a complete response, achieving NED status 6.5 years ago and recently being declared cured using chemotherapy 10.5 years after having stage IV disease.

Jump to this post

Good news. Thanks for sharing your journey!

REPLY
Please sign in or register to post a reply.